1. Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Issue 6 (30th April 2020) Authors: Irie, Hiroki; Kawabata, Rumi; Fujioka, Yayoi; Nakagawa, Fumio; Itadani, Hiraku; Nagase, Hideki; Ito, Kimihiro; Uchida, Junji; Ohkubo, Shuichi; Matsuo, Kenichi Journal: Cancer science Issue: Volume 111:Issue 6(2020) Page Start: 2123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗